Head-to-head · Cost-Efficiency Index
Evernow vs Society of You
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Evernow
Cost-first shoppers who want women 40+ wanting GLP-1 prescribing integrated with menopause/hormone care, ideally with insurance.
Visit EvernowSociety of You
Shoppers open to completing an eligibility quiz before seeing any price, since none is public.
Visit Society of YouThe verdict
Evernow and Society of You tie on the Cost-Efficiency Index at 49/100, so neither wins outright on the numbers. For most shoppers we'd start with Evernow (ranked #421, a hair above #425) — Cost-first shoppers who want women 40+ wanting GLP-1 prescribing integrated with menopause/hormone care, ideally with insurance. But Society of You is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Evernow.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Evernow | Society of You |
|---|---|---|
| Cost-Efficiency Index | 49/100 | 49/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #421 | #425 |
Evernow
49/100Where the value is
- Confirmed genuine GLP-1 prescribing (not hormone-therapy-only, despite the brand's menopause focus)
- Only prescribes FDA-approved branded medications, no compounded-drug quality uncertainty
- Available in all 50 states plus D.C.
The tradeoffs
- No cash-pay price published anywhere -- cost is insurance-dependent and opaque to uninsured shoppers
- No compounded option for patients priced out of branded GLP-1s
Society of You
49/100Where the value is
- Offers both compounded and branded GLP-1 options (Ozempic/Wegovy/Mounjaro) plus microdosing
- Part of a broader longevity/performance platform with sexual health and skin/hair verticals
- Mobile apps available on iOS and Android
The tradeoffs
- No public pricing page -- the linked /pricing URL 404s, so cost is fully gated behind signup
- No named medical director found in reachable content
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.